📢 Shenzhen–Hong Kong Stock Connect Update

The Shenzhen Stock Exchange has announced an update to the Hong Kong Stock Connect eligible securities list.

🆕 Key Change

Myway Biopharma-B has been added to the list of eligible stocks.

📅 Effective Date

April 28,2026

🔍 What This Means

The Stock Connect program links mainland China and Hong Kong markets, allowing cross-border trading.

👉 By being included:

Mainland Chinese investors can now buy shares of Myway Biopharma-B through the program

The stock may see higher liquidity and trading volume

Potential for increased investor attention and price volatile

🧠 Why It Matters

Inclusion in Stock Connect often:

Signals growing recognition of the company

Improves accessibility for institutional investors

Can lead to short-term price movements

---

If you want, I can:

Analyze whether Myway Biopharma-B stock is a good buy

Explain how Stock Connect impacts prices historically

Or list other recent additions/removals

Just tell me 👍